Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.35 USD | 0.00% | +44.63% | -82.93% |
Apr. 15 | Ampio Pharmaceuticals, Inc.(NYSEAM:AMPE) dropped from S&P TMI Index | CI |
Mar. 27 | Ampio Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 1.71M |
---|---|---|---|---|---|
Net income 2022 | -16M | Net income 2023 | -8M | EV / Sales 2022 | - |
Net cash position 2022 | 11.88M | Net cash position 2023 | 3.67M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.15
x | P/E ratio 2023 |
-0.19
x | Employees | 6 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98.44% |
1 week | +44.63% | ||
Current month | -61.96% | ||
1 month | -79.17% | ||
3 months | -78.40% | ||
6 months | -87.18% | ||
Current year | -82.93% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Martino
CEO | Chief Executive Officer | 68 | 21-10-12 |
Howard Levy
CTO | Chief Tech/Sci/R&D Officer | 70 | 21-10-12 |
Laura Goldberg
LAW | General Counsel | - | 13-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Stevens
BRD | Director/Board Member | 75 | 11-05-31 |
J. Buchi
CHM | Chairman | 69 | 21-10-12 |
Michael Martino
CEO | Chief Executive Officer | 68 | 21-10-12 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.35 | 0.00% | 4,821 |
24-04-24 | 0.35 | +22.38% | 11,208 |
24-04-23 | 0.286 | -16.13% | 8,022 |
24-04-22 | 0.341 | -31.26% | 825 |
24-04-19 | 0.4961 | +104.99% | 7,872 |
Delayed Quote OTC Markets, April 25, 2024 at 02:48 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-82.93% | 397K | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.79% | 22.02B | |
-17.84% | 20.9B | |
-11.11% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- AMPE Stock